Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Proffered Abstracts - Poster Presentations

Abstract 29: Molecular epidemiology of Gc-globulin isotype, circulating 25(OH)D levels, and uptake of vitamin D metabolites in colon cancer cells.

Elizabeth A. Hibler, Elizabeth T. Jacobs and Peter W. Jurutka
Elizabeth A. Hibler
1University of Arizona, Tucson, AZ, 2Arizona State University, Phoenix, AZ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth T. Jacobs
1University of Arizona, Tucson, AZ, 2Arizona State University, Phoenix, AZ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter W. Jurutka
1University of Arizona, Tucson, AZ, 2Arizona State University, Phoenix, AZ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.GWAS-29 Published November 2012
  • Article
  • Info & Metrics
Loading

Abstract

Associations between low circulating vitamin D metabolite concentrations and risk for colorectal neoplasia are demonstrated by numerous studies. Gc-globulin (GC) is the transport protein for vitamin D metabolites and isotypes of the protein, based on two nonsynonymous polymorphisms (rs7041 and rs4588), have different frequencies by race and ethnicity. The phenotype groups are 1F_1F, 1F_1S, 1S_1S, 1F_2, 1S_2 and 2_2. There is evidence that the GC isotypes have varying affinities for 25(OH)D and 1α,25(OH)2D, which may affect delivery of vitamin D metabolites at the cellular level. Furthermore, epidemiologic studies have demonstrated higher circulating 25(OH)D in individuals with copies of the 1S allele. Significantly different levels of vitamin D target gene transcription in monocytes treated with 25(OH)D and serum containing known GC isotype have also been observed. However, there is not yet evidence that uptake of 1α,25(OH)2D varies with GC isotype or evidence for variation in uptake of either metabolite in colon cancer cell lines, specifically. We therefore conducted an epidemiological association study of GC isotype and circulating vitamin D metabolite concentrations, as well as experiments to investigate vitamin D metabolite uptake in colon cancer cells. The VDR-RXR mammalian-two-hybrid (M2H) and vitamin D responsive element (VDRE)-based luciferase assay systems were employed for the latter study. HCT-116 cells were dosed with ethanol vehicle or various concentrations of 1α,25(OH)2D or 25(OH)D in the presence of plasma from individuals with known GC isotype. Luciferase assays were then conducted to measure metabolite uptake and activation of the VDR pathway in these cells. The epidemiological analysis demonstrated statistically significantly lower 25(OH)D for Caucasian participants with at least one copy of the GC_2 allele (p < 0.01) compared to the 1F or 1S phenotypes. The cellular-level data showed overall statistically significant differences in uptake of 1α,25(OH)2D by GC isotype (p < 0.001) as well as across 1α,25(OH)2D concentrations (10−8 to 5×10−10 M) (p<0.001). Overall, the 1F_1F, 1F_1S and 1F_2 isotypes produced the greatest induction of the luciferase reporter gene in the M2H system; while the 2_2, 1S_2 and 1S_1S isotypes displayed lower activity. Similar results for 1α,25(OH)2D were obtained using the VDRE assay system. The induction by 25(OH)D was statistically significantly associated with GC isotype in the VDRE-based system (p<0.001), but not with the M2H system (p = 0.36). However, stratification by concentration demonstrated that system activation was significantly different by GC isotype for all 25(OH)D concentrations in the VDRE system (p<0.01), but only the two highest concentrations of 5×10−7 M and 2×10−7 M with the M2H assay (p< 0.05). The induction by genotype varied more with 25(OH)D, though the 2_2 isotype again exhibited consistently lower activation. These results suggest that GC isotype alters the delivery of 1α,25(OH)2D and, potentially to a lesser extent, 25(OH)D to colon cells. These results may help identify additional populations at risk for disease related to the vitamin D endocrine system. Alternate methodologies for cellular-level experiments and repeated evaluation in epidemiological studies are necessary, especially to account for variation by race/ethnicity. Studying Gc-globulin phenotype in combination with circulating metabolite levels may improve our understanding of vitamin D deficiency and its relation to health outcomes.

Citation Format: Elizabeth A. Hibler, Elizabeth T. Jacobs, Peter W. Jurutka. Molecular epidemiology of Gc-globulin isotype, circulating 25(OH)D levels, and uptake of vitamin D metabolites in colon cancer cells. [abstract]. In: Proceedings of the AACR Special Conference on Post-GWAS Horizons in Molecular Epidemiology: Digging Deeper into the Environment; 2012 Nov 11-14; Hollywood, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(11 Suppl):Abstract nr 29.

  • ©2012 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 21 (11 Supplement)
November 2012
Volume 21, Issue 11 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 29: Molecular epidemiology of Gc-globulin isotype, circulating 25(OH)D levels, and uptake of vitamin D metabolites in colon cancer cells.
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract 29: Molecular epidemiology of Gc-globulin isotype, circulating 25(OH)D levels, and uptake of vitamin D metabolites in colon cancer cells.
Elizabeth A. Hibler, Elizabeth T. Jacobs and Peter W. Jurutka
Cancer Epidemiol Biomarkers Prev November 1 2012 (21) (11 Supplement) 29; DOI: 10.1158/1055-9965.GWAS-29

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 29: Molecular epidemiology of Gc-globulin isotype, circulating 25(OH)D levels, and uptake of vitamin D metabolites in colon cancer cells.
Elizabeth A. Hibler, Elizabeth T. Jacobs and Peter W. Jurutka
Cancer Epidemiol Biomarkers Prev November 1 2012 (21) (11 Supplement) 29; DOI: 10.1158/1055-9965.GWAS-29
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Proffered Abstracts - Poster Presentations

  • Abstract 79: The relationship between abdominal fat distribution, vitamin D levels, and physical activity in colorectal cancer patients: A pilot study.
  • Abstract 81: Dietary supplement use among German colorectal cancer patients: The ColoCare Study.
  • Abstract 82: Gene expression induced by acrylamide and glycidamide in mammalian cells.
Show more Proffered Abstracts - Poster Presentations

Molecular Epidemiology and Gene-Environment Interactions

  • Abstract PR2: Pathway-based gene-environment interactions in ovarian cancer.
  • Abstract PR6: Genetically determined differences in arsenic metabolism efficiency influence risk for premalignant skin lesions in Bangladesh: Mendelian randomization and gene-environment interaction.
  • Abstract PR1: LINE-1 %5-methyl cytosine levels in prediagnostic leukocyte DNA and future bladder cancer risk among PLCO and ATBC cohort subjects.
Show more Molecular Epidemiology and Gene-Environment Interactions
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement